Abstract
Background: Balloon aortic valvuloplasty (BAV) is currently used as pre-treatment for patients undergoing trans-catheter aortic valve replacement (TAVR) as well as a stand-alone option for subjects with significant contraindications to TAVR. Mammoth is a newly available non-compliant balloon catheter (BC) included in the balloon-expandable Myval THV system (Meril Life Sciences Pvt. Ltd., India). As limited data on the performance of this BC are available, we here report the results following its use for BAV as pre-dilatation during TAVR or as a stand-alone procedure. Methods: A retrospective, single-center cohort analysis was performed on patients with severe aortic valve stenosis (AS) treated with the Mammoth BC at IRCCS Ospedale Galeazzi Sant’Ambrogio, Milan, Italy. The primary endpoint was technical success defined as successful Mammoth BC advancement across the AS followed by its full and homogeneous inflation without major complications such as aortic root/left ventricular outflow tract injury and/or stroke. Results: A total of 121 patients were treated by BAV with Mammoth BC during the study period. Among these, 105 patients underwent BAV pre-dilatation before TAVR while 16 patients underwent a stand-alone BAV procedure. Mammoth BC was delivered and successfully inflated at the target site in all of the 121 cases without BC-related complications (100% technical success). However, in the BAV “stand-alone group”, three patients required two different balloon sizes while in nine patients multiple rounds (two to three) of balloon inflation were needed to significantly lower the transvalvular gradient. No cases of aortic root injury or massive aortic regurgitation due to Mammoth BC-related aortic leaflet injury were reported while one major stroke occurred late after TAVR. No intra-procedural deaths occurred nor bleeding (BARC 3-4) or major vascular complication. Conclusions: Mammoth BC use in patients with severe AS proved safe and effective, either before TAVR or as a stand-alone procedure, expanding the range of available tools for structural operators.
Share and Cite
MDPI and ACS Style
Moscardelli, S.; Caminiti, R.; Montonati, C.; Ceresa, F.; De Blasio, G.; Vizzari, G.; Pellegrini, D.; Pellicano, M.; Guagliumi, G.; Patanè, F.;
et al. Performance of the Mammoth Balloon Catheter in Patients with Severe Aortic Valve Stenosis Undergoing Percutaneous Treatment. J. Clin. Med. 2024, 13, 5986.
https://doi.org/10.3390/jcm13195986
AMA Style
Moscardelli S, Caminiti R, Montonati C, Ceresa F, De Blasio G, Vizzari G, Pellegrini D, Pellicano M, Guagliumi G, Patanè F,
et al. Performance of the Mammoth Balloon Catheter in Patients with Severe Aortic Valve Stenosis Undergoing Percutaneous Treatment. Journal of Clinical Medicine. 2024; 13(19):5986.
https://doi.org/10.3390/jcm13195986
Chicago/Turabian Style
Moscardelli, Silvia, Rodolfo Caminiti, Carolina Montonati, Fabrizio Ceresa, Giuseppe De Blasio, Giampiero Vizzari, Dario Pellegrini, Mariano Pellicano, Giulio Guagliumi, Francesco Patanè,
and et al. 2024. "Performance of the Mammoth Balloon Catheter in Patients with Severe Aortic Valve Stenosis Undergoing Percutaneous Treatment" Journal of Clinical Medicine 13, no. 19: 5986.
https://doi.org/10.3390/jcm13195986
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details
here.
Article Metrics
Article Access Statistics
For more information on the journal statistics, click
here.
Multiple requests from the same IP address are counted as one view.